...
首页> 外文期刊>Oncology letters >Cisplatin regulates cell autophagy in endometrial cancer cells via the PI3K/AKT/mTOR signalling pathway
【24h】

Cisplatin regulates cell autophagy in endometrial cancer cells via the PI3K/AKT/mTOR signalling pathway

机译:顺铂通过PI3K / AKT / MTOR信号通路调节子宫内膜癌细胞中的细胞自噬

获取原文
获取原文并翻译 | 示例
           

摘要

Endometrial cancer is the most common gynaecological malignancy encountered in developed countries and the second most common in the developing world. The five-year survival rate of patients with endometrial cancer diagnosed at a late stage is <30%. Therefore, it is critical to develop a suitable chemotherapeutic regimen for late-stage endometrial cancer. Cisplatin (CDDP) is a first-line chemotherapeutic drug.for endometrial cancer chemotherapy. The present study investigated the molecular mechanism underlying the effect of CDDP on endometrial cancer from the perspective of cell autophagy. Ishikawa cells were treated with 10, 20, 40 or 80 mu g/ml CDDP for 12, 24, 48 and 72 h. The cells were then harvested and subjected to cell proliferation assays. Based on the results, 20 mu g/mL CDDP was selected as the treatment used for 12 and 24 h for the assays. To detect the effect of CDDP on Ishikawa cell autophagy, autophagosome formation was observed using a transmission electron microscope, and the expression level of autophagy-related gene microtubule-associated protein 1 light chain 3(x, was examined using.immunotluorescence microscopy. The results demonstrated that CDDP treatment promoted cell autophagy in Ishikawa cells. In addition, the total and phosphorylatcd protein levels of phosphoinositide 3-kinase (PI3K) p85, protein kinase B (AKT) and mammalian target of rapamycin (mTOR), the key proteins of the PI3K/AKT/mTOR signalling pathway, were detected by western blot analysis. The results indicated that CDDP treatment inactivated the PI3K/AKTimTOR signalling pathway. To further examine whether CDDP affects cell autophagy in Ishikawa cells via the PI3K/AKT/mTOR signalling pathway, the cells were co-treated with a PI3K activator, insulin-like growth factor-1. (IGE-1). The results demonstrated that IGF-1 co-treatment reversed the effect of CDDP on cell autophagy in Ishikawa cells. In brief, the present study hypothesized that CDDP may regulate cell autophagy in the Ishikawa endometrial cancer cell line via the PI3K/AKT/mTOR signalling pathway.
机译:子宫内膜癌是发达国家遇到的最常见的妇科恶性肿瘤,以及发展中国家最常见的妇科恶性肿瘤。在晚期诊断的子宫内膜癌患者的五年存活率<30%。因此,为晚期子宫内膜癌发育合适的化学治疗方案至关重要。顺铂(CDDP)是一级化学治疗药物。对于子宫内膜癌化疗。本研究研究了CDDP对细胞自噬视角下CDDP对子宫内膜癌的影响的分子机制。用10,20,40或80μmg/ ml CDDP进行12,24,48和72h处理。然后收获细胞并进行细胞增殖测定。基于该结果,选择20μg/ ml CDDP作为用于测定的12和24小时的处理。为了检测CDDP对Ishikawa细胞自噬的影响,使用透射电子显微镜观察自动组血体形成,以及使用荧光显微镜检查自噬相关基因微管相关蛋白1轻链3(x的表达水平。结果证明CDDP治疗促进了Ishikawa细胞中的细胞自噬。此外,磷酸膦酸的总和磷酸盐蛋白水平3-激酶(PI3K)P85,蛋白激酶B(Akt)和哺乳动物靶雷帕霉素(MTOR)的关键蛋白质通过Western印迹分析检测PI3K / AKT / MTOR信号通路。结果表明,CDDP治疗灭活了PI3K / AkTimtor信号通路。进一步检查CDDP是否通过PI3K / AKT / MTOR信号传导路径在Ishikawa细胞中影响细胞自噬。用PI3K活化剂,胰岛素样生长因子-1共同处理细胞。(IgE-1)。结果表明IGF-1合作逆转效果ISHikawa细胞中细胞自噬的CDDP。简而言之,本研究假设CDDP可以通过PI3K / AKT / MTOR信号通路调节Ishikawa子宫内膜癌细胞系中的细胞自噬。

著录项

  • 来源
    《Oncology letters》 |2017年第2期|共5页
  • 作者单位

    Southern Med Univ Zhujiang Hosp Dept Gynecol &

    Obstet 18th Floor 253 Ind Ave Guangzhou 510280;

    Southern Med Univ Zhujiang Hosp Dept Gynecol &

    Obstet 18th Floor 253 Ind Ave Guangzhou 510280;

    Guangzhou Med Univ Affiliated Hosp 3 Dept Gynecol &

    Obstet Guangzhou 510150 Guangdong Peoples;

    Guangzhou Med Univ Affiliated Hosp 3 Dept Gynecol &

    Obstet Guangzhou 510150 Guangdong Peoples;

    Guangzhou Med Univ Affiliated Hosp 3 Dept Gynecol &

    Obstet Guangzhou 510150 Guangdong Peoples;

    Guangzhou Med Univ Affiliated Hosp 3 Dept Gynecol &

    Obstet Guangzhou 510150 Guangdong Peoples;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

    endometrial cancer; autophagy; PI3K/AKT/mTOR; cisplatin;

    机译:子宫内膜癌;自噬;pi3k / akt / mtor;cisplatin;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号